Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MARK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GOT1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASEF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100130468 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HECW2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRPX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1RL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF33B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EFCAB11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAATS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC171 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAAO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on